A


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
01 11 2023
Historique:
received: 11 04 2023
accepted: 20 10 2023
medline: 3 11 2023
pubmed: 2 11 2023
entrez: 2 11 2023
Statut: epublish

Résumé

There is significant clinical interest in targeting adenosine-mediated immunosuppression, with several small molecule inhibitors having been developed for targeting the A

Identifiants

pubmed: 37914685
doi: 10.1038/s41467-023-42734-0
pii: 10.1038/s41467-023-42734-0
pmc: PMC10620403
doi:

Substances chimiques

Cytokines 0
Adora2a protein, mouse 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6990

Informations de copyright

© 2023. The Author(s).

Références

J Clin Invest. 2017 Mar 1;127(3):929-941
pubmed: 28165340
Nature. 2020 Jul;583(7817):609-614
pubmed: 32581358
Cancer Immunol Res. 2015 May;3(5):506-17
pubmed: 25672397
Cancer Immunol Res. 2018 Oct;6(10):1136-1149
pubmed: 30131376
Cancer Immunol Res. 2014 Jul;2(7):598-605
pubmed: 24990240
Science. 2020 Dec 11;370(6522):1328-1334
pubmed: 33303615
J Mol Med (Berl). 2014 Dec;92(12):1283-92
pubmed: 25120128
Immunity. 2020 May 19;52(5):825-841.e8
pubmed: 32396847
Sci Signal. 2021 Mar 16;14(674):
pubmed: 33727336
J Immunol. 2018 Jul 15;201(2):782-791
pubmed: 29802128
Cancer Res. 2018 Feb 15;78(4):1003-1016
pubmed: 29229601
J Exp Med. 2013 Nov 18;210(12):2693-706
pubmed: 24145516
Cancer Immunol Res. 2020 Apr;8(4):465-478
pubmed: 32047024
Immunol Lett. 2020 Jul;223:44-52
pubmed: 32289340
Bioinformatics. 2012 Jun 1;28(11):1530-2
pubmed: 22539670
Eur J Immunol. 2010 Mar;40(3):682-7
pubmed: 20039304
Blood. 2008 Sep 1;112(5):1822-31
pubmed: 18559975
J Exp Med. 2007 Jun 11;204(6):1257-65
pubmed: 17502665
Clin Respir J. 2018 Jan;12(1):149-157
pubmed: 27216911
Cancer Res. 2014 Dec 15;74(24):7239-49
pubmed: 25341542
J Immunol. 2013 Oct 1;191(7):3712-24
pubmed: 24006458
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
Nat Immunol. 2023 Feb;24(2):267-279
pubmed: 36543958
Nat Immunol. 2020 Nov;21(11):1346-1358
pubmed: 32868929
Sci Transl Med. 2015 Mar 4;7(277):277ra30
pubmed: 25739764
J Immunother Cancer. 2018 Jun 18;6(1):57
pubmed: 29914571
Cancer Immunol Res. 2020 Aug;8(8):1064-1074
pubmed: 32381524
Blood. 1997 Aug 15;90(4):1600-10
pubmed: 9269779
J Immunol. 2005 Oct 1;175(7):4383-91
pubmed: 16177079
Nat Commun. 2018 Jul 13;9(1):2724
pubmed: 30006565
J Immunol. 2012 Jan 1;188(1):198-205
pubmed: 22116822
Curr Opin Pharmacol. 2020 Aug;53:134-145
pubmed: 33022543
Proc Natl Acad Sci U S A. 2013 Sep 3;110(36):14711-6
pubmed: 23964122
J Immunother Cancer. 2020 Jul;8(2):
pubmed: 32727810
Cancer Discov. 2020 Jan;10(1):40-53
pubmed: 31732494
Cancer Immunol Res. 2018 Jul;6(7):812-824
pubmed: 29720380
Cancer Res. 2014 Dec 15;74(24):7250-9
pubmed: 25377469
Cancer Immunol Res. 2020 Oct;8(10):1311-1321
pubmed: 32759363
Nat Rev Clin Oncol. 2020 Oct;17(10):611-629
pubmed: 32514148
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4265-73
pubmed: 16857801
Cell. 2019 Apr 18;177(3):556-571.e16
pubmed: 30955881
Exp Cell Res. 2021 Dec 1;409(1):112886
pubmed: 34673000
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nature. 2001 Dec 20-27;414(6866):916-20
pubmed: 11780065
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):11091-6
pubmed: 23776241
Cancer Immunol Immunother. 2012 Jun;61(6):917-26
pubmed: 22116345
Nat Commun. 2021 May 28;12(1):3236
pubmed: 34050151
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13132-7
pubmed: 16916931
Blood. 2005 Jun 15;105(12):4707-14
pubmed: 15746085
J Clin Invest. 2020 Nov 2;130(11):5629-5637
pubmed: 32870821
Nucleic Acids Res. 2018 Jan 4;46(D1):D754-D761
pubmed: 29155950
Cancer Discov. 2020 Jan;10(1):16-19
pubmed: 31919119
Int J Mol Sci. 2018 Dec 02;19(12):
pubmed: 30513816
Am J Cancer Res. 2014 Mar 01;4(2):172-81
pubmed: 24660106
Cancer Res. 2010 Mar 15;70(6):2245-55
pubmed: 20179192
Front Cell Dev Biol. 2021 Apr 13;9:647058
pubmed: 33928082
Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008
pubmed: 31028147
J Immunol. 2005 Jan 15;174(2):1073-80
pubmed: 15634932
J Exp Clin Cancer Res. 2020 Mar 10;39(1):49
pubmed: 32151275

Auteurs

Kirsten L Todd (KL)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia. Kirsten.Todd@petermac.org.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia. Kirsten.Todd@petermac.org.

Junyun Lai (J)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Kevin Sek (K)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Yu-Kuan Huang (YK)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Dane M Newman (DM)

Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.
Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.

Emily B Derrick (EB)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Hui-Fern Koay (HF)

Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
Australian Research Council Centre of Excellence in Advanced Molecular Imaging, University of Melbourne, Melbourne, VIC, Australia.

Dat Nguyen (D)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Thang X Hoang (TX)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Emma V Petley (EV)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Cheok Weng Chan (CW)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Isabelle Munoz (I)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Imran G House (IG)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Joel N Lee (JN)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Joelle S Kim (JS)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Jasmine Li (J)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Junming Tong (J)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Maria N de Menezes (M)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Christina M Scheffler (CM)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Kah Min Yap (KM)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Amanda X Y Chen (AXY)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Phoebe A Dunbar (PA)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Brandon Haugen (B)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Ian A Parish (IA)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.

Ricky W Johnstone (RW)

Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.
Translational Hematology Program, Peter MacCallum Cancer Centre, Melbourne, Australia.

Phillip K Darcy (PK)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia.
Department of Immunology, Monash University, Clayton, Australia.

Paul A Beavis (PA)

Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, 3000, VIC, Australia. paul.beavis@petermac.org.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, 3010, Australia. paul.beavis@petermac.org.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH